PIK3CD and cancer: Intratumoural administration of IC87114, a small molecule inhibitor with selectivity for p110δ41, from day +15, when the tumour was palpable, significantly reduced tumour volume (Fig. 2a) suggesting that the inhibition of p110δ affects the proliferation of cancer cells and/or cells of the tumour microenvironment.